QHSLab, Inc. Files 8-K Report
Ticker: USAQ · Form: 8-K · Filed: Sep 17, 2024 · CIK: 856984
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
QHSLab (QHS) filed an 8-K on 9/17/24 for Reg FD and financials.
AI Summary
On September 17, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is incorporated in Nevada and operates in the Surgical & Medical Instruments & Apparatus industry.
Why It Matters
This filing provides important updates and disclosures for QHSLab, Inc., which could impact investor understanding of the company's current status and regulatory compliance.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report detailing disclosures and exhibits, without immediate news of significant financial events or strategic shifts.
Key Players & Entities
- QHSLab, Inc. (company) — Registrant
- September 17, 2024 (date) — Date of earliest event reported
- USA EQUITIES CORP. (company) — Former company name
- AMERICAN BIOGENETIC SCIENCES INC (company) — Former company name
- Nevada (jurisdiction) — State of Incorporation
- 3841 (sic_code) — Standard Industrial Classification
FAQ
What is the primary purpose of this 8-K filing for QHSLab, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on September 17, 2024.
What is QHSLab, Inc.'s state of incorporation?
QHSLab, Inc. is incorporated in Nevada.
What industry does QHSLab, Inc. operate in, according to its SIC code?
QHSLab, Inc. operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry, with SIC code 3841.
What were some of QHSLab, Inc.'s former company names?
QHSLab, Inc. was formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC.
Filing Stats: 662 words · 3 min read · ~2 pages · Grade level 11.2 · Accepted 2024-09-17 09:00:09
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value USAQ N/A Item 7.01 Regu
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 19KB
- ex99-1_001.jpg (GRAPHIC) — 20KB
- 0001493152-24-036548.txt ( ) — 259KB
- usaq-20240917.xsd (EX-101.SCH) — 3KB
- usaq-20240917_lab.xml (EX-101.LAB) — 33KB
- usaq-20240917_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: September 17, 2024 QHSLab, Inc. /s/ Troy Grogan Name: Troy Grogan Title: CEO and Chairman